Daniel Gordon Kirby

CIK: 0002055001

Transaction Breakdown

Open Market Buys (P)1 (7.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (30.8%)

Derivative conversions

Awards (A)4 (30.8%)

Compensation grants

Other (G, F, J, C, D, …)4 (30.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IOVA

IOVANCE BIOTHERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Aug 10, 2026
Tax Payment(F)
Direct
2.4K shares at avg. $6.40$16K
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Aug 10, 2026
Exercise(M)
Direct
10K shares-
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
May 11, 2026
Exercise(M)
Direct
10K shares-
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
May 11, 2026
Tax Payment(F)
Direct
2.4K shares at avg. $3.70$9K
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Mar 9, 2026
Award(A)
Restricted Stock Units
Direct
132.2K shares-
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Feb 24, 2026
Tax Payment(F)
Direct
34.2K shares at avg. $3.78$129K
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Feb 24, 2026
Exercise(M)
Direct
120K shares-
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Feb 10, 2026
Tax Payment(F)
Direct
16.5K shares at avg. $2.60$43K
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Feb 10, 2026
Exercise(M)
Direct
40K shares-
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Jun 5, 2025
Purchase(P)
Direct
30K shares at avg. $1.84$55K
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Feb 10, 2025
Award(A)
Restricted Stock Units
Direct
120K shares-
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Feb 10, 2025
Award(A)
Performance Stock Units
Direct
150K shares-
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Feb 10, 2025
Award(A)
Stock Options (Right to Buy)
Direct
35K shares-

		Type	Shares	Price		Ownership
Aug 10, 2026	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Tax Payment(F)	2,436	$6.40	$15,590	Direct
Aug 10, 2026	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Exercise(M)	10,001	-	$0	Direct
May 11, 2026	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Exercise(M)	10,000	-	$0	Direct
May 11, 2026	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Tax Payment(F)	2,435	$3.70	$9,010	Direct
Mar 9, 2026	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Award(A) Restricted Stock Units	132,200	-	-	Direct
Feb 24, 2026	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Tax Payment(F)	34,165	$3.78	$129,144	Direct
Feb 24, 2026	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Exercise(M)	120,000	-	$0	Direct
Feb 10, 2026	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Tax Payment(F)	16,450	$2.60	$42,770	Direct
Feb 10, 2026	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Exercise(M)	39,996	-	$0	Direct
Jun 5, 2025	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Purchase(P)	30,000	$1.84	$55,200	Direct
Feb 10, 2025	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Award(A) Restricted Stock Units	120,000	-	-	Direct
Feb 10, 2025	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Award(A) Performance Stock Units	150,000	-	-	Direct
Feb 10, 2025	IOVA IOVANCE BIOTHERAPEUTICS, INC.	Award(A) Stock Options (Right to Buy)	35,000	-	-	Direct

1-13 of 13 transactions

About Kirby Daniel Gordon

Kirby Daniel Gordon (SEC CIK 0002055001) files insider reports with the SEC as Chief Commercial Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA).

Signal8 holds 8 ownership filings by Kirby Daniel Gordon (1 Form 3, 7 Form 4), filed between Feb 12, 2025 and Aug 12, 2026. Those filings report 13 transactions, from Feb 10, 2025 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kirby Daniel Gordon's filings is in SAN CARLOS, CA.

Recent filings by Kirby Daniel Gordon

Aug 10, 2026: Tax withholding of IOVA shares (Form 4, code F).
Aug 10, 2026: Option exercise of IOVA shares (Form 4, code M).
May 11, 2026: Option exercise of IOVA shares (Form 4, code M).
May 11, 2026: Tax withholding of IOVA shares (Form 4, code F).
Mar 9, 2026: Grant or award of IOVA derivative securities (Form 4, code A).

Other insiders filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Berkowitz Noah, Chief Medical Officer
Vogt Frederick G, Interim CEO & General Counsel
BILINSKY IGOR, Chief Operating Officer
Puri Raj K., Chief Regulatory Officer
Roche Corleen M., Chief Financial Officer
WEISER MICHAEL, Director

How to read Form 4 transaction codes